Introduction {#Sec1}
============

Exposure to stress is thought to precipitate several neuropsychiatric disorders (Mazure et al*.*[@CR71]). Chronic stress has significant impact on the cellular integrity and function of certain brain areas, most notably the limbic structures (Joels et al*.*[@CR51]; McEwen [@CR73]). In most studies, the hippocampal formation has been investigated as a crucial structure, but recently the prefrontal cortex (PFC) has been seen as equally important (Czeh et al*.*[@CR26]).

Prefrontal cortex in rodents participates in the higher-order functions including learning, memory, event association, the temporal sequencing of tasks, specific aspects of locomotor activity, spatial navigation, decision making, and goal-directed behavior (Pirot et al. [@CR91]; Vertes [@CR109]). PFC plays a key role in working memory, recalling memories from long-term storage, as well as recent memories to guide behavior, while inhibiting inappropriate responses and distractions (Ramos and Arnsten [@CR93]; Robbins [@CR94]). All of these abilities depend on proper PFC network connections, which are vulnerable to stress and neurochemical environment (Arnsten [@CR6]). PFC contributes to negative feedback control of the hypothalamic--pituitary--adrenal axis (HPA) (Herman et al*.*[@CR46]) and regulates the stress responses of other structures (Amat et al*.*[@CR4]; Pascucci et al. [@CR87]). Based on observations from clinical, neuropsychological, and neuroimaging studies, dysfunction of the PFC has been suspected to be accountable for some depressive symptoms (Cummings [@CR25]; Deutch [@CR29]; Fibiger [@CR36]). Dolan et al. ([@CR32]) have provided evidence that neuropsychological symptoms in depression are associated with profound hypometabolism, particularly involving the medial PFC (Dolan et al. [@CR32]). Both bipolar and unipolar affective disorders can be identified by decreases in cerebral blood flow and the rate of glucose metabolism in the PFC (Drevets [@CR33]; Drevets et al*.*[@CR34]).

Animal studies indicate that exposure to acute or chronic stress can alter the activity of the neuroendocrine and neurotransmitter systems that affect behavior. Stress in rodents induces anxiety, enhanced fear, anhedonia, and depression (Bekris et al. [@CR12]; Bergstrom et al. [@CR14]; D'Aquila et al. [@CR27]; Wood et al*.*[@CR113]). Chronic stress reduces dopaminergic and serotonergic transmission in the PFC (Mizoguchi et al*.*[@CR77]) and results in a depressive state. Exposure to mild uncontrollable stress impairs PFC functions in humans and animals (Arnsten [@CR6]). Loss of self-control during stress can lead to maladaptive behaviors such as alcohol and drug addiction, smoking, and overeating (Li and Sinha [@CR60]). Stress can also exacerbate the symptoms of bipolar disorders and schizophrenia (Breier et al*.*[@CR19]; Dohrenwend [@CR31]).

Preclinical observations can help to understand stress-related processes in the human brain of genetically stress-vulnerable individuals. Because the responses should differ between the subjects displaying different sensitivity to stress, in the present study we investigated the effects of chronic mild stress (CMS) on gene expression in the frontal cortex of mice selected for high (HA strain) or low (LA strain) stress reaction measured by magnitude of swim stress-induced analgesia (Panocka et al*.*[@CR85]). The unstressed strains display profound differences in a number of behavioral tests reflecting anxiety or depression. HA mice exhibit higher acoustic startle response (Błaszczyk et al. [@CR15]; Juszczak et al. [@CR54]) and longer depression-like behavior (immobility) in the tail suspension (TST) and forced swim (FST) tests (Juszczak et al*.*[@CR55], [@CR53]; Panocka et al*.*[@CR86]) than the LA strain. The strains also differ in responses to a variety of antidepressants. Desipramine (a prototypic tricylic antidepressant), venlafaxine (selective serotonin reuptake inhibitor), and aminosenktide (tachykinin NK3---receptor agonist) shortened the immobility time of HA mice in the FST or TST, but were ineffective in the LA strain (Juszczak et al. [@CR53]; Panocka et al*.*[@CR86]).

Using gene expression profiling and bioinformatics methodology we now attempted to identify candidate genes, physiological pathways, and potential mechanisms of mood disorders in the PFC of mice that differ in depression-like responses and are exposed to CMS.

Experimental Procedures {#Sec2}
=======================

Animals {#Sec3}
-------

Male Swiss Webster mice (weighing 25--30 g, 12 weeks of age), from two lines selected for 76 generations for high (HA) and low (LA) swim stress-induced analgesia (SIA) were used (Panocka et al. [@CR84]). Adult males and females from each generation, after completion of 3-min swim in 20 °C water, were tested for pain sensitivity on a hot-plate heated to 56 °C. Latency of characteristic hind paw flick or lick response was scored. The animals displaying the longest (50--60 s) and the shortest (\<10 s) post-swim latencies of the nociceptive response were chosen for further breeding. Animals were given ordinary daily care with free access to food and water and kept at ambient temperature of 22 ± 1 °C. All procedures had been approved by the Local Ethics Commission and carried out in accordance with the Guiding Principles for the Care and Use of Research Animals.

Chronic Mild Stress {#Sec4}
-------------------

The animals were assigned to two treatment groups. Control animals (control HA mice, *n* = 15, and control LA mice, *n* = 15) were given ordinary daily care with free access to food and water, while the stressed animals were exposed for 5 weeks to chronic mild stress (CMS HA mice, *n* = 15, and CMS LA mice, *n* = 15). CMS was adapted from the procedures developed by Willner et al. ([@CR112]) and used in our previous study, Lisowski et al. ([@CR63]). Stressors were applied in a pseudo-random manner during both light and dark phases. All mice received the same treatment schedule, with treatments occurring in different orders in different weeks. The control and CMS groups of mice were housed in single cages and separately in different rooms.

Sample Preparation {#Sec5}
------------------

Two days after the end of the CMS, the animals were gently removed from their cages and quickly decapitated within 30 s, the brains were removed and placed on ice-cold glass dish, and prefrontal cortices were immediately isolated (Hamon [@CR44]), aliquoted into freezing vials, frozen in liquid nitrogen, and stored at −80 °C until analysis. Total RNA was isolated, separately from each prefrontal cortex, using NucleoSpin RNA II kit (Macherey-Nagel, Germany), according to the manufacturer\'s protocol. Nanodrop (Nanodrop, USA) and Bioanalyzer (Agilent, USA) estimated quantity and quality of each RNA sample, and the RIN (RNA Integrity Number) index ranged from 9.4 to 9.8 for all samples.

For each microarray, total RNA samples from five animals were pooled and quantity and quality of the pooled samples estimated once again by the Nanodrop and Bioanalyzer. Biotinylated cRNA was prepared using the Illumina RNA Amplification Kit (Ambion Inc., USA) according to the manufacturer\'s protocol and starting with 100 ng total RNA. Samples were purified with the RNeasy kit (Qiagen, Germany) according to the manufacturer\'s protocol.

Microarray, Hybridization, and Fluorescent Detection {#Sec6}
----------------------------------------------------

Hybridization to the Sentrix MouseRef-8 Expression BeadChip (Illumina, USA), washing, and scanning were performed according to the Illumina BeadStation 500× manual. Sentrix MouseRef-8 Expression BeadChip contains approximately 24,000 well-annotated RefSeq 50-mer oligonucleotide probes per array. Data were extracted using software provided by the manufacturer. Illumina Beadstudio v2 software with the default settings for gene expression analysis was used.

Data Normalization and Selection of Differentially Expressed Genes {#Sec7}
------------------------------------------------------------------

Raw microarray data were processed with BeadArray and LIMMA package of the Bioconductor project (Bioconductor project; [www.bioconductor.org](http://www.bioconductor.org)). Data preprocessing step involved normalization of expression levels with quantile method was preceded by log2 transformation. Linear model fitting was performed for the pre-processed dataset. The empirical Bayes analysis was performed in order to identify differentially expressed genes by testing whether the contrast coefficients from the linear models can be assumed equal zero. Genes considered to be significantly differentially expressed with logged fold-change are greater than 0.5 and adjusted *p* value is less than 0.05. Benjamini and Hochberg method ([@CR13]), for controlling false discovery rate, was used to correct *p* values.

Bioinformatics, Database Search, and Gene Enrichment Analysis {#Sec8}
-------------------------------------------------------------

### Gene Ontology Analysis {#Sec9}

Gene lists (GenBank accession numbers) from microarray results were submitted to the Expression Analysis Systemic Explorer (EASE; <http://david.abcc.ncifcrf.gov>). EASE takes into account the frequencies of genes belonging to particular Gene Ontology terms (GO; <http://www.geneontology.org/index.shtml>) among the genes found to be regulated and among all genes studied in the experiment. EASE performs statistical analysis to detect overrepresented functional gene categories in the data set compared with all genes on the arrays. GO terms are reported with corresponding EASE scores---it is a conservative statistical test that gives the upper bound of the distribution of the Jackknife Fisher exact probabilities and favors robust categories. Functional gene categories were considered significantly overrepresented at *p* \< 0.05. Genes to functional categories were classified with biological process, molecular function, and cellular component ontologies.

### KEGG Biochemical Pathways Analysis {#Sec10}

Analysis of the genes\' association with physiological pathways was performed using the Kyoto Encyclopedia of Genes and Genomes database (KEGG; <http://www.genome.jp/kegg/pathway.html>). In KEGG database, distributions of the differentially expressed genes were classified among biochemical pathways. Microarray data from a single gene in a pathway do not suffice to describe a regulatory mechanism of the pathway. Therefore, only pathways with the microarray information for at least two genes were considered. To identify significantly overrepresented biological categories and KEGG pathways within the lists of differentially expressed genes, the threshold of EASE Score for the enrichment analysis was set at *p* ≤ 0.05.

### Functional Clustering {#Sec11}

For a more insightful view of the relationships between annotation categories compared with chart, genes were clustered in the DAVID 6.7 Functional Annotation Clustering module (<http://david.abcc.ncifcrf.gov/>). Biologically meaningful clusters consist of genes that are annotated into specific functional annotation groups. Grouping genes based on functional similarity can systematically enhance biological interpretation of large lists of genes derived from high throughput studies. The Functional Classification Tool generates a gene-to-gene similarity matrix based on shared functional annotation using over 75,000 terms from 14 functional annotation sources. DAVID clustering algorithms classifies highly related genes into functionally related groups. The classification stringency of the cluster analysis was set at "high" level. To avoid over-counting duplicated genes in the chart report view, the Fisher exact statistics was calculated based on corresponding DAVID gene IDs by which all redundancies in original IDs are removed.

### Quantitative Real-Time Reverse Transcription PCR {#Sec12}

To validate the results of microarrays, quantitative real-time RT-PCR (qPCR) with SYBR Green technique was performed as described previously (Lisowski et al. [@CR63]). Seven genes belonging to different functional groups and significantly differing in expression between the control and CMS mice of each strain were selected. qPCR assays were carried out in triplicates on the same but non-pooled individual RNA samples (*n* = 15) per experimental group RNA samples, which were used in the microarray experiment. For reference, two housekeeping genes, selected from ten commonly used reference genes using previous methodology (Lisowski et al. [@CR61], [@CR62]) stably expressed in mouse hippocampus in applied experimental assay and belonging to different functional classes, were used: glyceraldehyde-3-phosphate dehydrogenase (*Gapdh*) and hypoxanthine guanine phosphoribosyl transferase 1 (*Hprt1*). Primers were designed using ExonPrimer software (<http://ihg2.helmholtz-muenchen.de/ihg/ExonPrimer.html>) (Institute of Human Genetics, TUM/Helmholtz Center Munich, Germany) using *Mus musculus* GenBank sequences. All primers produced amplicons which spanned two exons each in highly conserved coding regions and included all known alternatively spliced mRNA variants

Data from three runs were calibrated by calculating the average cycle threshold value over samples in each run and the results were calculated using the mathematical model for relative quantification in qPCR described by Pfaffl ([@CR89]). To test for the effects of the observational groups on target genes mRNA level, t-test was performed (SAS version 8.02; SAS Institute, NC). Results are reported as the mean ± standard error of the mean (SEM). Differences between the groups were considered significant at *p* \< 0.05. The degree of significance and the correlation between fold changes, as determined in the microarray analysis and those determined by qPCR, was evaluated with the Pearson moment correlation.

Results {#Sec13}
=======

Expression profiling was designed to determine the impact of genetic background (two selectively bred strains) on the transcriptional effects of CMS in prefrontal cortex. Gene analysis was performed by one color hybridization of the 24 K microarray in HA and LA, naïve and CMS mice. Three independent biological replicates of microarray were prepared for each group of mice. To minimize the influence of individual differences between the animals and variation introduced by dissection and tissue preparation, total RNA separately isolated from several PFCs was pooled. Each pool, containing total RNA from five individuals, was separately converted to cRNA and hybridized to a single microarray.

The identified genes are considered to be expressed in the prefrontal cortex according to Novartis Gene Expression Atlas (<http://www.biogps.gnf.org/>). Cell-type classification analysis of differentially expressed genes, according to Cahoy ([@CR22]), GeneCards Database (<http://www.genecards.org/>) screening and Ingenuity Pathway Analysis (IPA) (<http://www.ingenuity.com/>) of top canonical pathways, revealed that most of them are characteristic for neurons and oligodendrocytes.

Differences in Basal Gene Expression of HA Mice Compared to LA {#Sec14}
--------------------------------------------------------------

Comparison of basal gene expression profiles between the HA and LA strains identified 193 transcripts with different levels of mRNA in the PFC that met the criteria of logged fold change greater than 0.5 and *p* \< 0.05. One hundred thirty-three of differentially expressed genes between the strains were upregulated and 60 genes were downregulated in HA as compared to LA. Expression of these genes differs at baseline in a genotype-dependent manner. The whole sets of probes that differed in naive HA vs. LA mice are presented in "Electronic Supplementary Material" (ESM) Table S[1](#MOESM1){ref-type="media"}**.** Genes annotated to these probe sets were considered to be expressed in the examined brain tissue according to Novartis Gene Expression Atlas ([www.biogps.gnf.org](http://www.biogps.gnf.org)).

Statistically significant (*p* \< 0.05) over-expressed biological processes terms associated with the up- and downregulated genes between strains were found with the DAVID Functional Annotation Tool. We identified functional categories of biological process (Fig. [1](#Fig1){ref-type="fig"}), molecular function (Fig. [2](#Fig2){ref-type="fig"}), and KEGG biochemical pathways terms (Fig. [3](#Fig3){ref-type="fig"}), including elements of neuron development and differentiation, dendrite development, protein transport and localization, lipid binding, calcium ion binding, phosphoinositide binding, cytoskeletal regulatory protein binding, long-term potentiation, VEGF, MAPK, and/or T cell signaling pathways.Fig. 1Significantly enriched (*p* \< 0.05) gene ontology (GO) biological process categories of differentially expressed genes in the prefrontal cortex of naïve high analgesia (HA) vs. naïve low analgesia (LA) miceFig. 2Significantly enriched (*p* \< 0.05) gene ontology (GO) molecular function categories of differentially expressed genes in the prefrontal cortex of naïve high analgesia (HA) vs. naïve low analgesia (LA) miceFig. 3Significantly enriched (*p* \< 0.05) Kyoto Encyclopedia of Genes and Genomes (KEGG) biochemical pathways of differentially expressed genes in the prefrontal cortex of naïve high analgesia (HA) vs. naïve low analgesia (LA) mice

GO and KEGG classifications on a list of significant upregulated transcripts was done in each strain. In general, genes upregulated in HA encode elements involved in processes such as dendrite development (*Mtap2*, *Mtap1b*, and *Pak1*), neuron projection (*Mtap2, Mtap1b*, *Stxbp1*, *Etv1*, and *Pak1*), cell communication (*Kif1b*, *Snx14*, *Snx17*, *Clstn1*, *Stxbp1*, *Snx2*, and *Ppp3ca*), synaptic transmission (*Kif1b*, *Clstn1*, *Stxbp1*, and *Ppp3ca*), lipid binding (*Snap91*, *Dgke*, *Snx14*, *Rasgrp1*, *Snx17*, *Snx2*, *Prkcc*, and *Sh3gl2*), and calcium ion binding (*Atp2c1*, *Rasgrp1*, *Itgav*, *Clstn1*, *Cacng3*, *Kcnip2*, *Capn2*, *Prkcc*, *1500003003rik*, and *Dtna)* (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}).Table 1Upregulated genes associated with the gene ontology (GO) biological process terms (*p* \< 0.05) in the prefrontal cortex of high analgesia (HA) miceGO biological processNumber of genesEASE scoreGenesEndocytosis60.002CAV2, ITGAV, SNX17, STXBP1, SH3GL2, ELMO1Membrane organization70.002CAV2, SNAP91, ITGAV, SNX17, STXBP1, SH3GL2, ELMO1Organelle organization120.014TSPYL1, EPB4,1L3, CAV2, SNAP91, ATP2C1, MTAP2, MTAP1B, STXBP1, CBX3, ACIN1, RBBP7, ELMO1Transport200.016GDI1, CAV2, SNAP91, SNX14, KCNAB1, SNX17, STXBP1, SNX2, ATP6V1G2, CACNG3, KCNIP2, ELMO1, RAB7, SLCO1A4, KIF1B, ATP2C1, ITGAV, PPP3CA, SH3GL2, SEC61A2Dendrite development30.016MTAP2, MTAP1B, PAK1Establishment of localization200.017GDI1, CAV2, SNAP91, SNX14, KCNAB1, SNX17, STXBP1, SNX2, ATP6V1G2, CACNG3, KCNIP2, ELMO1, RAB7, SLCO1A4, KIF1B, ATP2C1, ITGAV, PPP3CA, SH3GL2, SEC61A2Cellular component organization170.018CAV2, SNAP91, MTAP2, SNX17, STXBP1, CBX3, RBBP7, ELMO1, TSPYL1, EPB4,1L3, ATP2C1, ITGAV, MTAP1B, ETV1, PAK1, ACIN1, SH3GL2Neuron projection50.023MTAP2, MTAP1B, STXBP1, ETV1, PAK1Vesicle-mediated transport70.027CAV2, SNAP91, ITGAV, SNX17, STXBP1, SH3GL2, ELMO1Cell communication70.028KIF1B, SNX14, SNX17, CLSTN1, STXBP1, SNX2, PPP3CAProtein transport80.040GDI1, SNX14, SNX17, STXBP1, SNX2, PPP3CA, SEC61A2, RAB7Synaptic transmission40.040KIF1B, CLSTN1, STXBP1, PPP3CATable 2Upregulated genes associated with the gene ontology (GO) molecular function terms (*p* \< 0.05) in the prefrontal cortex of high analgesia (HA) miceGO molecular functionNumber of genesEASE scoreGenesLipid binding80.002SNAP91, DGKE, SNX14, RASGRP1, SNX17, SNX2, PRKCC, SH3GL2Phosphoinositide binding40.006SNAP91, SNX14, SNX17, SNX2Cytoskeletal regulatory protein binding20.017MTAP2, MTAP1BPhospholipid binding40.024SNAP91, SNX14, SNX17, SNX2Calcium ion binding100.025ATP2C1, RASGRP1, ITGAV, CLSTN1, CACNG3, KCNIP2, CAPN2, PRKCC, 1500003O03RIK, DTNAProtein binding390.026CAV2, SNAP91, SNX14, SNX17, CLSTN1, SNX2, CBX3, ATP6V1G2, COPS8, ARPC5, FBXW7, SFRS5, CASP9, ITGAV, INSIG1, BTBD3, ZFP238, PPP3CA, PAK1, RNF14, SEC61A2, DTNA, MTAP2, EEF1A2, STXBP1, CAPN2, RBBP7, PPP1CB, ELMO1, EPB4,1L3, MAPK1, ATF4, KIF1B, BTG1, MTAP1B, LASS1, HSPD1, CD200, SH3GL2Diacylglycerol binding30.035DGKE, RASGRP1, PRKCC

To find significantly over-represented pathways in the list of differentially expressed genes, we searched the KEGG database. In the HA mice prefrontal cortex, significantly overrepresented pathways were the long-term potentiation, focal adhesion, NK mediated cytotoxicity, VEGF, MAPK, T cell receptor, axon guidance, regulation of actin cytoskeleton, apoptosis, Fc gamma R-mediated phagocytosis and Alzheimer\'s disease pathways (Table [3](#Tab3){ref-type="table"}).Table 3Upregulated genes associated with the Kyoto Encyclopedia of Genes and Genomes (KEGG) biochemical pathways (*p* \< 0.05) in the prefrontal cortex of high analgesia (HA) miceKEGG biochemical pathwayNumber of genesEASE scoreGenesLong-term potentiation60.000MAPK1, ATF4, PPP3CA, PPP1CB, PRKCC, 1500003O03RIKNatural killer cell-mediated cytotoxicity60.001MAPK1, H2-T23, PPP3CA, PAK1, PRKCC, 1500003O03RIKMAPK signaling pathway80.001MAPK1, ATF4, RASGRP1, CACNG3, PPP3CA, PAK1, PRKCC, 1500003O03RIKFocal adhesion70.001MAPK1, CAV2, ITGAV, PAK1, CAPN2, PPP1CB, PRKCCVEGF signaling pathway50.001MAPK1, CASP9, PPP3CA, PRKCC, 1500003O03RIKT cell receptor signaling pathway50.004MAPK1, RASGRP1, PPP3CA, PAK1, 1500003O03RIKApoptosis40.014CASP9, PPP3CA, CAPN2, 1500003O03RIKAlzheimer\'s disease50.015MAPK1, CASP9, PPP3CA, CAPN2, 1500003O03RIKFc gamma R-mediated phagocytosis40.017MAPK1, PAK1, ARPC5, PRKCCRegulation of actin cytoskeleton50.036MAPK1, ITGAV, PAK1, ARPC5, PPP1CBAxon guidance40.038MAPK1, PPP3CA, PAK1, 1500003O03RIKAmyotrophic lateral sclerosis (ALS)30.042CASP9, PPP3CA, 1500003O03RIK

Genes upregulated in LA are involved in neuron differentiation (*Sema5a*, *Exoc7*, *Pcsk9*, and *Rpgrip1*), response to stimulus (*Crhr1*, *Bat5*, *Ercc5*, *S100a8*, *Camp*, *S100a9*, *Pcsk9*, *Mpo*, *Rpgrip1*, and *Psmb9)*, structural constituent of ribosome (*Mrps18c*, *Rpl6*, and *Rps15a)*, and coding cellular components such as cytosol and cytoplasmic parts (*Actb*, *Bat5*, *Exoc7*, *Camp*, *Rps15a*, *Psmb9*, *Mrps18c*, *Rpl6*, *Tor1b*, *Pcsk9*, *Ltf*, *Mpo*, *Neu1*, *Pdrg1*, *Tomm22*, *Slc4a1*, *Hbb-b2*, and *Srp9)*, cell cortex parts (*Actb*, *Exoc7*, and *Slc4a1*), macromolecular complex (*Bat5*, *Mrps18c*, *Kif3a*, *Exoc7*, *Rpl6*, *Rps15a*, *Pdrg1*, *Hbb-b2*, *Srp9*, *Itgbl1*, and *Psmb9)*, secretory granule and cytoplasmic membrane-bounded vesicle (*Camp*, *Mpo*, *Ltf*, and *Neu1*), and ribosome (*Mrps18c*, *Rpl6*, and *Rps15a*) (Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}). Among the genes upregulated in LA mice, no statistically significant KEGG biochemical pathways were found.Table 4Upregulated genes associated with the gene ontology (GO) biological process terms (*p* \< 0.05) in the prefrontal cortex of low analgesia (LA) miceGO biological processNumber of genesEASE scoreGenesNeuron differentiation40.046SEMA5A, EXOC7, PCSK9, RPGRIP1Response to stimulus100.048CRHR1, BAT5, ERCC5, S100A8, CAMP, S100A9, PCSK9, MPO, RPGRIP1, PSMB9Generation of neurons40.049SEMA5A, EXOC7, PCSK9, RPGRIP1Table 5Upregulated genes associated with the gene ontology (GO) molecular function terms (*p* \< 0.05) in the prefrontal cortex of low analgesia (LA) miceGO molecular functionNumber of genesEASE scoreGenesStructural constituent of ribosome30.033MRPS18C, RPL6, RPS15A

Effects of Chronic Mild Stress on Gene Expression in HA and LA Mice {#Sec15}
-------------------------------------------------------------------

The influence of genetic background on gene expression level was estimated. Using the same statistical criteria, the comparisons of PFC transcriptomic profiles of naive vs. CMS animals revealed 96 in HA and 92 in LA differentially expressed transcripts. In HA strain, 59 of differentially expressed were upregulated and 37 genes were downregulated after CMS (ESM Table S[2](#MOESM2){ref-type="media"}), while in LA strain, 60 genes were upregulated and 32 were downregulated as a result of CMS (ESM Table S[3](#MOESM3){ref-type="media"}). There was also some overlap in the expression profiles between the strains: 23 common transcripts were changed in both strains (Table [6](#Tab6){ref-type="table"}). Within the list of the overlapping genes, according to DAVID Functional Clustering Tool, eight genes coded cell membrane parts (*Rab5b*, *Cntnap4*, *Ai593442*, *Pigt*, *Tomm22*, *Rgs9*, *Rasd2*, and *Calb2*), six genes were classified into signal transduction and intracellular signaling cascade cluster (*Rab5b*, *Cntnap4*, *Dgkg*, *Rgs9*, *Mtss1l*, and *Rasd2)*, three genes into ion binding cluster (*Dgkg*, *Nell2*, and *Calb2*), and three genes into transport and establishment and localization cluster (*Ttr*, *Rab5b*, and *Tomm22*) (Table [7](#Tab7){ref-type="table"}).Table 6Common transcripts with overlapping changes in the prefrontal cortex of high (HA) and low (LA) analgesia mice followed chronic mild stress (CMS)Gene symbolDefinitionExpressionHA fold changeLA fold changeTtrTransthyretin (Ttr)↑6.092.54Tomm22Translocase of outer mitochondrial membrane 22↑↓2.75−2.18C1ql2Complement component 1, q subcomponent-like 2↑1.321.481300006M19RikRIKEN cDNA 1300006 M19 gene↑2.262.380610009K11RikMitochondrial ubiquitin ligase activator of NFKB 1↑↓2.12−1.58Wdr6WD repeat domain 6 (Wdr6)↑1.971.56Mtss1lMetastasis suppressor 1-like↑1.451.55BC040774↑2.462.20BC060632↑1.861.65Nell2Nel-like 2 homolog (chicken) (Nell2)↑1.542.29Calb2calbindin 2 (Calb2)↑1.691.29Rab5bRAB5B, member RAS oncogene family (Rab5b)↑1.582.36Krt1-12Keratin complex 1, acidic, gene 12 (Krt1-12)↑↓1.61−1.37NnatNeuronatin (Nnat), transcript variant 2↑1.501.83DgkgDiacylglycerol kinase, gamma (Dgkg)↑1.301.25C630041L24RikRIKEN cDNA C630041L24 gene↑1.281.35Cntnap4Contactin-associated protein 4 (Cntnap4)↑0.520.75Ddx6DEAD (Asp-Glu-Ala-Asp) box polypeptide 6↓−1.38−1.46AI593442*Mus musculus* expressed sequence AI593442↓−1.51−1.68Rasd2RASD family, member 2↓−1.73−1.64IndoIndoleamine-pyrrole 2,3 dioxygenase↓−2.19−1.89Rgs9Regulator of G-protein signaling 9 (Rgs9)↓−2.35−2.31PigtPhosphatidylinositol glycan, class T (Pigt)↓−3.22−1.25"↑" upregulation, "↓" downregulationTable 7Clusters of overlapping transcripts determined by the DAVID v6.7 software (*p* \< 0.05)Gene symbolDefinitionSignal transduction/intracellular signaling cascade Rab5bRAB5B, member RAS oncogene family Rasd2RASD family, member 2 Cntnap4Contactin-associated protein-like 4 DgkgDiacylglycerol kinase, gamma Mtss1lMetastasis suppressor 1-like Rgs9Regulator of G-protein signaling 9Calcium ion binding/metal ion binding/cation binding Nell2NEL-like 2 (chicken) Calb2Calbindin 2 DgkgDiacylglycerol kinase, gammaTransport/establishment of localization Rab5bRAB5B, member RAS oncogene family Tomm22Translocase of outer mitochondrial membrane 22 homolog TtrTransthyretinMembrane part Rab5bRAB5B, member RAS oncogene family Rasd2RASD family, member 2 Calb2Calbindin 2 Cntnap4Contactin-associated protein-like 4 AI593442Expressed sequence AI593442 PigtPhosphatidylinositol glycan anchor biosynthesis Tomm22Translocase of outer mitochondrial membrane 22 homolog Rgs9Regulator of G-protein signaling 9

Statistically significant (*p* \< 0.05) over-expressed terms associated with the up- and downregulated genes were found in both strains subjected to CMS. Functional annotation was done in each strain on a list of up- and downregulated transcripts separately. In HA mice, CMS affected the upregulation of genes involved in, e.g., intracellular signaling, ion binding, neuropeptide hormone activity, and metabolism of cAMP and nucleotides (Fig. [4a](#Fig4){ref-type="fig"}). Downregulated genes were those involved in ion transport, reproductive and mating behavior, neuron differentiation and dendrite development, cell communication, regulation of insulin secretion and response to insulin stimulus, regulation of transport, homeostasis, focal adhesion, ion channel activity, or MAPK signaling pathway (Fig. [4b](#Fig4){ref-type="fig"}).Fig. 4Significantly enriched (*p* \< 0.05) gene ontology (GO) categories of genes affected by chronic mild stress (CMS) in the prefrontal cortex of high analgesia (HA) mice: **a** upregulated transcripts, and **b** downregulated transcripts. GO categories shown in the figure consists of biological processes, molecular functions, cellular components, and biochemical pathways

In LA mice, CMS affected the upregulation of genes involved in the activation of protein kinase C, regulation of transcription, calcium ion binding, hormone binding, or coding elements of dendrites (Fig. [5a](#Fig5){ref-type="fig"}). Downregulated genes were involved in locomotory behavior, signal transduction and immunity processes, or long-term depression (Fig. [5b](#Fig5){ref-type="fig"}).Fig. 5Significantly enriched (*p* \< 0.05) gene ontology (GO) categories of genes affected by chronic mild stress (CMS) in the prefrontal cortex of low analgesia (LA) mice: **a** upregulated transcripts, and **b** downregulated transcripts. GO categories shown in the figure consists of biological processes, molecular functions, cellular components and biochemical pathways

For more detailed data interpretation, we performed the functional clustering of DEGs. Functional clustering of DEGs between stressed vs. control animals revealed several functional groups of genes in each strain. Altogether, 11 main clusters were found for HA (Table [8](#Tab8){ref-type="table"}) and 12 for LA (Table [9](#Tab9){ref-type="table"}). Specific clusters for HA strain contain genes involved in regulation of hormone secretion/regulation of insulin secretion, ion binding, regulation of primary metabolic process/regulation of cAMP biosynthetic process, and cell junction/adherens junction. Specific clusters for LA strain contain genes involved in response to stress, dendrite/neuron projection, immune effector process/immune response, intracellular signaling cascade/GTPase regulator activity and cognition. Functional clustering revealed similar clusters in both lines despite containing different genes. Overlapping clusters in both strains were clusters such as signal transduction, response to stimulus, regulation of biological quality and homeostasis, cell differentiation, apoptosis and cell death, regulation of transcription and gene expression, and signal transducer/receptor activity. Clusters were identified in the list of the significantly upregulated and downregulated genes in non stressed vs*.* stressed animals. Tables [8](#Tab8){ref-type="table"} and [9](#Tab9){ref-type="table"} present significant functional clusters with differentially expressed genes and their expression values.Table 8Clusters of genes determined by the DAVID v6.7 software (*p* \< 0.05) affected by chronic mild stress (CMS) in the prefrontal cortex of high analgesia (HA) miceGene symboalGene nameExpressionFold ChangeRegulation of cell communication/regulation of signal transduction Bat2HLA-B-associated transcript 2↑1.48 Acvr1cActivin A receptor, type IC↓−2.10 Bai1Brain-specific angiogenesis inhibitor 1↑1.61 Dkk3Dickkopf homolog 3 (Xenopus laevis)↓−1.48 Drd1aDopamine receptor D1A↓−1.28 Mtap1bMicrotubule-associated protein 1B↓−1.45 PalmParalemmin↑1.34 Cbx3Predicted gene 6917; similar to chromobox homolog 3↓−2.17 Rgs9Regulator of G-protein signaling 9↓−2.35 Sostdc1Sclerostin domain containing 1↑1.50 Srp9Signal recognition particle 9↑2.49 Timp2Tissue inhibitor of metalloproteinase 2↑1.55Regulation of hormone secretion/regulation of insulin secretion Bat2HLA-B-associated transcript 2↑1.48 Acvr1cActivin A receptor, type IC↓−2.10 AvpArginine vasopressin↑3.67 Drd1aDopamine receptor D1A↓−1.28 Il12aInterleukin 12a↓−1.32 KlKlotho↓−2.20 NnatNeuronatin↑1.50 PfkmPhosphofructokinase, muscle↓−1.83Ion binding Arl3ADP-ribosylation factor-like 3↑3.10 Lasp1LIM and SH3 protein 1↓−1.85 Nell2NEL-like 2 (chicken)↑1.70 Acvr1cActivin A receptor, type IC↓−2.10 Calb2Calbindin 2↑1.69 Cacna2d1Calcium channel, voltage-dependent, alpha2/delta subunit 1↓−1.38 Calml4Calmodulin-like 4↑1.52 Clic6Chloride intracellular channel 6↑1.77 DgkgDiacylglycerol kinase, gamma↑1.30 Hpcal4Hippocalcin-like 4↑1.22 KlKlotho↑1.92 Mmp17Matrix metallopeptidase 17↓−1.26 Myl4Myosin, light polypeptide 4↓−1.50 PfkmPhosphofructokinase, muscle↓−1.83 Kcnb1Potassium voltage gated channel, Shab-related subfamily↓−1.98 Kcnh1Potassium voltage-gated channel, subfamily H (eag-related)↓−1.85 PnckPregnancy upregulated non-ubiquitously expressed CaM kinase↑1.40 PrkcbProtein kinase C, beta↓−0.65 SparcSecreted acidic cysteine rich glycoprotein↑1.54 Slc17a7Solute carrier family 17↑1.22 Zfp423Zinc finger protein 423; similar to mKIAA0760 protein↑1.42 Zcchc12Zinc finger, CCHC domain containing 12↑1.89Regulation of primary metabolic process/regulation of cAMP biosynthetic process AvpArginine vasopressin↑3.67 Drd1aDopamine receptor D1A↓−1.28 PalmParalemmin↑1.34 Kcnh1Potassium voltage-gated channel, subfamily H↓−1.85 Cbx3Predicted gene 6917; similar to chromobox homolog 3↓−2.17 Rbbp4Retinoblastoma binding protein 4↓−1.87 Srp9Signal recognition particle 9↑2.49 Timp2Tissue inhibitor of metalloproteinase 2↑1.55 Zfp423Zinc finger protein 423; similar to mKIAA0760 protein↑1.42 Zcchc12Zinc finger, CCHC domain containing 12↑1.89Cell junction/adherens junction Lasp1LIM and SH3 protein 1↓−1.85 Calb2Calbindin 2↑1.69 Cbln1Cerebellin 1 precursor protein; similar to precerebellin-1↓−2.06 Pak1p21 protein (Cdc42/Rac)-activated kinase 1↓−2.06 Pkp2Plakophilin 2↑1.26 Slc17a7Solute carrier family 17↑1.22Response to endogenous stimulus/response to hormone stimulus Bat2HLA-B-associated transcript 2↑1.48 Bat5HLA-B-associated transcript 5↑3.36 Rasd2RASD family, member 2↓−1.73 Acvr1cActivin A receptor, type IC↓−2.10 AvpArginine vasopressin↑3.67 Drd1aDopamine receptor D1A↓−1.28 H2-LHistocompatibility 2, D region; histocompatibility 2↑2.56 Il12aInterleukin 12a↓−1.32 NnatNeuronatin↑1.50 Ppp1r1bProtein phosphatase 1, regulatory (inhibitor) subunit 1B↓−1.68 PtpraProtein tyrosine phosphatase, receptor type, A↓−1.78 Rgs9Regulator of G-protein signaling 9↓−2.35 Slc17a7Solute carrier family 17↑1.22 TrhThyrotropin-releasing hormone↑1.91Homeostatic process/regulation of biological quality AvpArginine vasopressin↑3.67 Drd1aDopamine receptor D1A↓−1.28 NtsNeurotensin↑1.58 PalmParalemmin↑1.34 PfkmPhosphofructokinase, muscle↓−1.83 PrkcbProtein kinase C, beta↓−0.65 Ppp1r1bProtein phosphatase 1, regulatory (inhibitor) subunit 1B↓−1.68 Slc17a7Solute carrier family 17↑1.22Generation of neurons/neurogenesis/neuron differentiation Acvr1cActivin A receptor, type IC↓−2.10 Dkk3Dickkopf homolog 3 (Xenopus laevis)↓−1.48 Drd1aDopamine receptor D1A↓−1.28 KlKlotho↑1.92 Mtap1bMicrotubule-associated protein 1B↓−1.45 NnatNeuronatin↑1.50 Pak1p21 protein (Cdc42/Rac)-activated kinase 1↓−2.06 PigtPhosphatidylinositol glycan anchor biosynthesis, class T↓−3.22 Pkp2Plakophilin 2↑1.26 PrlrProlactin receptor↑1.62 Sostdc1Sclerostin domain containing 1↑1.50 Timp2Tissue inhibitor of metalloproteinase 2↑1.55 Zfp423Zinc finger protein 423; similar to mKIAA0760 protein↑1.42Apoptosis/cell death Bat2HLA-B-associated transcript 2↑1.48 Acvr1cActivin A receptor, type IC↓−2.10 PigtPhosphatidylinositol glycan anchor biosynthesis, class T↓−3.22Regulation of gene expression/regulation of transcription Kcnh1Potassium voltage-gated channel, subfamily H↓−1.85 Cbx3Predicted gene 6917; similar to chromobox homolog 3↓−2.17 Rbbp4Retinoblastoma binding protein 4↓−1.87 Srp9Signal recognition particle 9↑2.49 Zfp423Zinc finger protein 423; similar to mKIAA0760 protein↑1.42 Zcchc12Zinc finger, CCHC domain containing 12↑1.89Signal transducer activity/receptor activity Acvr1cActivin A receptor, type IC↓−2.10 Bai1Brain-specific angiogenesis inhibitor 1↑1.61 Drd1aDopamine receptor D1A↓−1.28 Folr1Folate receptor 1 (adult)↑1.23 Igsf1Immunoglobulin superfamily, member 1↑2.09 Kcnh1Potassium voltage-gated channel, subfamily H↓−1.85 Tomm22Predicted gene 12906; predicted gene 7250↑2.75 PrlrProlactin receptor↑1.62 PtpraProtein tyrosine phosphatase, receptor type, A↓−1.78 Rgs9Regulator of G-protein signaling 9↓−2.35"↑" upregulation, "↓" downregulationTable 9Clusters of genes determined by the DAVID v6.7 software (*p* \< 0.05) affected by chronic mild stress (CMS) in the prefrontal cortex of low analgesia (LA) miceGene symbolGene nameExpressionFold changeSignal transduction Fcer1gFc receptor, IgE, high affinity I, gamma polypeptide↓−2.66 Gpr88G-protein coupled receptor 88↓−1.23 Rab5bRAB5B, member RAS oncogene family↑2.36 Rasgrp1RAS guanyl-releasing protein 1↑1.31 Rasd2RASD family, member 2↓−1.64 Cntnap4Contactin-associated protein-like 4↑0.75 Crhr1Corticotropin-releasing hormone receptor 1↓−1.76 DgkeDiacylglycerol kinase, epsilon↑1.66 DgkgDiacylglycerol kinase, gamma↑1.25 Grm5Glutamate receptor, metabotropic 5↓−0.95 Gdi1Guanosine diphosphate (GDP) dissociation inhibitor 1↑1.99 MatkMegakaryocyte-associated tyrosine kinase↓−1.53 PrkccProtein kinase C, gamma↑2.54 Rgs9Regulator of G-protein signaling 9↓−2.31 Spock2Sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2↑1.44Response to stress Fcer1gFc receptor, IgE, high affinity I, gamma polypeptide↓−2.66 Rasd2RASD family, member 2↓−1.64 S100a8S100 calcium binding protein A8 (calgranulin A)↓−3.78 S100a9S100 calcium binding protein A9 (calgranulin B)↓−3.32 Capn2Calpain 2↑3.76 CampCathelicidin antimicrobial peptide↓−1.72 Crhr1Corticotrophin-releasing hormone receptor 1↓−1.76 Grm5Glutamate receptor, metabotropic 5↓−0.95 Mt3Metallothionein 3↑1.89 MpoMyeloperoxidase↓−1.85 NnatNeuronatin↑1.83 Igh-VJ558Predicted gene 5353; immunoglobulin heavy chain (J558 family)↓−1.63 PrkccProtein kinase C, gamma↑2.54 Rgs9Regulator of G-protein signaling 9↓−2.31Dendrite/neuron projection Crmp1Collapsin response mediator protein 1↑1.36 Cntnap4Contactin-associated protein-like 4↑0.75 PrkccProtein kinase C, gamma↑2.54Immune effector process/immune response Atp6v0a1ATPase, H + transporting, lysosomal V0 subunit A1↑1.62 Fcer1gFc receptor, IgE, high affinity I, gamma polypeptide↓−2.66 S100a9S100 calcium binding protein A9 (calgranulin B)↓−3.32 MpoMyeloperoxidase↓−1.85 Igh-VJ558Predicted gene 5353; immunoglobulin heavy chain (J558 family)↓−1.63Intracellular signaling cascade/GTPase regulator activity Rab5bRAB5B, member RAS oncogene family↑2.36 Rasgrp1RAS guanyl-releasing protein 1↑1.31 Rasd2RASD family, member 2↓−1.64 DgkeDiacylglycerol kinase, epsilon↑1.66 DgkgDiacylglycerol kinase, gamma↑1.25 Gdi1Guanosine diphosphate (GDP) dissociation inhibitor 1↑1.99 PrkccProtein kinase C, gamma↑2.54 Rgs9Regulator of G-protein signaling 9↓−2.31Behavior/response to external stimulus Fcer1gFc receptor, IgE, high affinity I, gamma polypeptide↓−2.66 Rasd2RASD family, member 2↓−1.64 S100a8S100 calcium binding protein A8 (calgranulin A)↓−3.78 S100a9S100 calcium binding protein A9 (calgranulin B)↓−3.32 Crhr1Corticotrophin-releasing hormone receptor 1↓−1.76 Grm5Glutamate receptor, metabotropic 5↓−0.95 PrkccProtein kinase C, gamma↑2.54Ion homeostasis/regulation of biological quality CrymCrystallin, mu↑1.85 Grm5Glutamate receptor, metabotropic 5↓−0.95 LtfLactotransferrin↓−2.59 Mt3Metallothionein 3↑1.89 Sepw1Selenoprotein W, muscle 1↑1.39 Slc26a4Solute carrier family 26, member 4↑1.32Nervous system development/cell differentiation Atp6v0a1ATPase, H + transporting, lysosomal V0 subunit A1↑1.62 Capn2Calpain 2↑3.76 Grm5Glutamate receptor, metabotropic 5↓−0.95 Kif3aKinesin family member 3A↓−1.97 LbhLimb-bud and heart↑1.50 Mt3Metallothionein 3↑1.89 MogMyelin oligodendrocyte glycoprotein↑1.37 NnatNeuronatin↑1.83 NfibNuclear factor I/B↑1.37 PigtPhosphatidylinositol glycan anchor biosynthesis, class T↓−1.25 PrkccProtein kinase C, gamma↑2.54 Rgs9Regulator of G-protein signaling 9↓−2.31 Slc26a4Solute carrier family 26, member 4↑1.32 ThraThyroid hormone receptor alpha; similar to thyroid hormone receptor↑1.31Regulation of apoptosis/regulation of programmed cell death Fcer1gFc receptor, IgE, high affinity I, gamma polypeptide↓−2.66 Eef1a2Eukaryotic translation elongation factor 1 alpha 2↑1.90 MalMyelin and lymphocyte protein, T-cell differentiation protein↑1.37Regulation of transcription/regulation of gene expression Atp6v0a1ATPase, H + transporting, lysosomal V0 subunit A1↑1.62 Atf4Activating transcription factor 4↑1.45 Brms1lBreast cancer metastasis-suppressor 1-like↑1.33 Eef1a2Eukaryotic translation elongation factor 1 alpha 2↑1.90 LbhLimb-bud and heart↑1.50 NfibNuclear factor I/B↑1.37 ThraThyroid hormone receptor alpha; similar to thyroid hormone receptor↑1.31 Zfp238Zinc finger protein 238↑1.81Signal transducer activity/receptor activity/G-protein coupled receptor activity Fcer1gFc receptor, IgE, high affinity I, gamma polypeptide↓−2.66 Gpr88G-protein coupled receptor 88↓−1.23 Crhr1Corticotrophin-releasing hormone receptor 1↓−1.76 Grm5Glutamate receptor, metabotropic 5↓−0.95 MogMyelin oligodendrocyte glycoprotein↑1.37 Tomm22Predicted gene 12906; predicted gene 7250↓−2.18 Rgs9Regulator of G-protein signaling 9↓−2.31 ThraThyroid hormone receptor alpha; similar to thyroid hormone receptor↑1.31Cognition Grm5Glutamate receptor, metabotropic 5↓−0.95 PrkccProtein kinase C, gamma↑2.54 Rgs9Regulator of G-protein signaling 9↓−2.31"↑" upregulation, "↓" downregulation

Validation of Microarrays {#Sec16}
-------------------------

To confirm differential expression indicated by the microarray expression patterns, the quantitative real-time reverse transcription PCR was used (qPCR). qPCR were performed using aliquots of the non-pooled total RNA. Following genes were selected from the list of the significant functional clusters in each strain: *Ttr*, *Drd1*, *Dgkg*, *Prkcb*, *VGluT1*, *Prlr*, and *Nts* for HA strain, and *Ttr*, *Crhr1*, *Dgke*, *Grm5*, *Prkcc*, *Gpm6a*, and *Mog* for LA strain. The expression patterns of the selected genes are shown in Fig. [6a](#Fig6){ref-type="fig"}, b. Similar trends in gene expression were shown as in the microarrays. Genes selected according to microarray analyses showed corresponding values with a high correlation. Correlation for the selected data points was *R* = 0.91 (*p* \< 0.0001).Fig. 6Validation of expression of the selected genes by qPCR: **a** HA control vs. HA followed by CMS; **b** LA control vs. LA followed by CMS. Results are presented as means of relative mRNA levels in 15 individuals per experimental group; error indicators show ± S.E.M. Values differ significantly at \* *p* \< 0.05, \*\* *p* \< 0.01 or \*\*\* *p* \< 0.001; qPCR values were normalized to geometric mean of the raw expression data of two reference genes: *Gapdh* and *Hprt1*. Abbreviations: *qPCR*, quantitative real-time RT-PCR; *HA*, high analgesia mice; *LA*, low analgesia mice; *CMS*, chronic mild stress; *S.E.M.*, standard error of measurement or mean; *Gapdh*, glyceraldehyde-3-phosphate dehydrogenase; *Hprt1*, hypoxanthine phosphoribosyltransferase 1

Discussion {#Sec17}
==========

Environmental factors and genes contribute to the manifestation of phenotype which, however, may occur or not. The proper activity of a complex organ such as the brain relies on precise temporal and spatial gene expression patterns. The phenotype is a result of a cascade of transcriptional events that finally triggers gene expression and determines the function of the particular brain structures. While a certain set of genes is constantly expressed to maintain the organ structure, a varying number of genes are regulated according to the metabolic demand of the surrounding organism. PFC is the brain region that is most sensitive to the detrimental effects of stress exposure. Abilities of PFC depend on proper neuronal network connections, which are highly sensitive to their neurochemical environment (Arnsten [@CR6]). Since exposure to even a mild uncontrollable stress can rapidly impair PFC functions, which contribute to PFC deficits and structural changes in human and animals, a good understanding of the genetic control of chronic stress exposure will facilitate further progress in understanding the pathophysiology of stress. Gene expression level could thus be a biomarker and provide information, for example, for psychiatric diagnosis.

It is important to have animal models of stress response to understand the mechanisms that render individuals vulnerable. In this study, we have focused on the comparison of prefrontal cortex transcription profiles between naive and stressed inbred mice strains with different sensitivity to stress. Studies of differences in gene expression were carried out with 24 K oligonucleotide microarrays for genome-wide gene expression analysis and the real-time RT-PCR technique for microarray validation. To determine the physiological processes that are differentially regulated between strains, the DAVID 6.7 Functional Annotation Tool was used.

For validation of oligonucleotide chip data, we performed real-time RT-PCR with the same RNA samples that was used for the microarray experiments. *Gapdh* and *Hprt1* were used as a reference. These genes were not regulated between HA and LA during stress procedure in our study and have been used successfully as a housekeeping control in previous study as well (Lisowski et al*.*[@CR63]). Other housekeeping genes that have been proposed such as beta actin were found to be regulated in brain between strains and/or stressed vs. control mice. In this study, the average fold change of correlation between microarray and qRT-PCR was 0.91 (*p* \< 0.0001). Large-scale study of real-time RT-PCR and gene expression measurements with commercial oligonucleotide microarrays concluded that microarrays are invaluable discovery tools with acceptable reliability for genome-wide gene expression screening, though validation of putative changes in gene expression remains advisable (Wang et al*.*[@CR110]).

Differences in Basal Gene Expression of HA Mice Compared to LA Mice {#Sec18}
-------------------------------------------------------------------

As a way of identifying stress-responsive candidate genes, we conducted gene expression profiling studies in the PFC of high (HA) and low (LA) swim stress-induced analgesia inbred mouse strains. The strains display robust differences in behavioral tests reflecting depression and in responses to different classes of antidepressants (desipramine, venlafaxine, and aminosenktide) (Błaszczyk et al*.*[@CR15]; Juszczak et al*.*[@CR54], [@CR55], [@CR53]; Panocka et al*.*[@CR84]). Experimental models of SIA help in identifying the fundamental mechanisms of stress response. The phenomenon that pain can be naturally suppressed leads to speculation that manipulation of the mechanisms of SIA could be a potential therapeutic target for stress- and anxiety-related disorders (Butler and Finn [@CR21]). It may also be possible to utilize the expression of SIA as a predictor for development of psychological disorders (Meeus et al*.*[@CR74]; Nishith et al*.*[@CR81]; Pielsticker et al*.*[@CR90]; Staud et al*.*[@CR100]).

Identification of 193 differentially expressed genes between the strains supported by functional classification showed that selective breeding seriously affected frontal cortex development in aspect of structural changes such as neuron projection, neuron development, neuron differentiation, membrane organization, or dendrite development. SIA is mediated by activation of the descending inhibitory pain pathway that originates in neurons in higher brain regions such as the cortex. Neurons in the cortex also relay nociceptive information to the amygdala, hypothalamus, or directly to the periaqueductal grey. The PFC has also been implicated in the recall and extinction of fear-related memory of noxious stimuli (Hugues et al*.*[@CR47]). Upregulation in the PFC of HA mice expression pattern of genes involved in calcium ion binding, lipid binding, diacyroglicerol binding, VEGF signaling, MAPK signaling, T cell receptor signaling, focal adhesion, or long-term potentiation suggests increased activation of neurons, leading to high analgesic phenotype and complex prefrontal cortex mechanisms of pain, stress, or fear.

Effects of Chronic Mild Stress on Gene Expression in HA and LA Mice {#Sec19}
-------------------------------------------------------------------

The chronic mild stress has been studied at the cellular level (Airan et al*.*[@CR2]; Banasr and Duman [@CR11]; Garcia-Garcia et al. [@CR40]; Gronli et al*.*[@CR43]; Jayatissa et al*.*[@CR49]; Warner-Schmidt and Duman [@CR111]). In addition to core symptoms of depression, such as long-lasting anhedonia (Elizalde et al*.*[@CR35]), CMS induces neuroadaptive changes that could be addressing clinical findings with depressed patients (Frodl et al. [@CR38]; Gould et al*.*[@CR42]; Lucassen et al*.*[@CR66]; Rajkowska [@CR92]; Sanacora et al*.*[@CR95]). Very little is known about the effects of chronic stress on transcriptome in the prefrontal cortex. Recent studies on primates demonstrate that social stress reduces the expression of many genes in the PFC that are involved in synaptic plasticity, cell cycle progression, and nuclear receptor signaling (Karssen et al*.*[@CR56]). According to Tordera ([@CR104]), CMS affected the regulation of 147 transcripts in a mouse CMS model, some of them involved in response to stress and oxidoreductase activity. Here, we aimed to identify in animals with different genetic background (HA CMS and LA CMS mice) specific gene expression profiles and common gene expression changes. We have identified genes similarly regulated by CMS in both strains. Overlapping genes with the same expression pattern in both mouse models are involved in coding elements of cell membrane part and are involved in signal transduction, calcium ion binding, and transport. We observed robust upregulation of *Ttr* gene coding transthyretin (TTR). Transthyretin is one of the three prealbumins: alpha-1-antitrypsin, transthyretin, and orosomucoid. Transthyretin is a carrier protein and a major transporter of thyroid hormones and retinol in the plasma and cerebrospinal fluid (Landers et al. [@CR59]). The diseases caused by mutations in *TTR* include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis, or carpal tunnel syndrome (Blevins et al*.*[@CR16]; Garzuly et al*.*[@CR41]; Jones et al*.*[@CR52]; Murakami et al*.*[@CR80], [@CR79]; Saraiva et al. [@CR96]). Clinical features of defects in *TTR* include seizures, stroke-like episodes, dementia, and psychomotor deterioration. The absence of TTR protein in TTR-null mice is associated with increased exploratory activity and reduced depression-like behavior (Sousa et al*.*[@CR98]). Cell cultures incubated with TTR oligomers were proven to induce cytotoxicity by Ca^2+^ efflux from the endoplasmic reticulum (Teixeira et al. [@CR102]). Moreover, recent observation conducted by Andrus ([@CR5]) classified *Ttr* to the set of genes whose hippocampal or amygdalar expression patterns were altered by chronic stress in four rat strains represent a generalizable molecular response to chronic stress. Taken together, we observed stress-associated significant cortical upregulation of *Ttr* and calcium ion binding genes (*Nell2*, *Calb2*, *Dgkg*) in both high and low analgesia mouse strains.

Given the genetic heterogeneity, it is likely that not all the subjects will show identical changes in all genes. We found that an individual\'s genetic make-up does make a serious difference in how the individual, at the gene expression level, responds to stress. Functional clustering revealed seven statistically significant overlapping groups of differentially expressed genes between control and stressed animals. Common clusters, in both strains, included genes involved in behavior, signal transduction, response to hormone stimulus, homeostasis, neuron differentiation, neurogenesis, and apoptosis. The HA strain-specific groups of genes were involved in regulation of insulin secretion, cAMP biosynthetic process and cell junction. The LA strain groups of genes were connected with response to stress, dendrite and neuron projection, immune response, GTP-ase activity, and cognition.

Exposure to chronic stress leads to extensive alterations in the architecture of PFC including loss of dendritic material (Brown et al*.*[@CR20]). Whereas structural changes in the hippocampus require several weeks of stress exposure, dendrites in the PFC begin to change after 1 week of stress or possibly even a single exposure (Brown et al*.*[@CR20]; Izquierdo et al. [@CR48]; McEwen [@CR72]). The signaling mechanisms that underlie these changes in the PFC are just beginning to be studied. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. Protein kinase C gamma type is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long-term potentiation (LTP) and long-term depression, specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development (Malmberg et al*.*[@CR69]). In our study, we have found that CMS decreased transcription of protein kinase C, beta (*Prkcc*) in HA mice and increased protein kinase C, gamma (*Prkcg*) in LA. Glucocorticoid release during stress could potentiate stress-signaling pathways through activation of PKC signaling (Han et al*.*[@CR45]).

Chronic stress alters catecholamine pathways increasing noradrenergic innervation of the PFC although dopamine becomes depleted with severe chronic stress (Miner et al. [@CR75]; Mizoguchi et al. [@CR76]). Increased noradrenaline might lead to higher levels of PKC and cAMP signaling (Arnsten [@CR6]). In LA mice, we have identified a cluster of genes downregulated by CMS which are involved in the cAMP biosynthetic process including the dopamine receptor D1A (*Drd1a*). Moreover, PKCs require Ca^2+^, diacylglycerol (DAG), and a phospholipid such as phosphatidylserine for activation. According to this, another interesting group of genes identified in LA mice was intracellular signaling cascade/GTP-ase regulator activity cluster. This cluster, besides *Prkcg* consist of several upregulated genes in LA CMS animals including diacylglycerol kinases epsilon (*Dgke*) and gamma (*Dgkg*) involved in PKC signaling.

Stress-induced changes in dendritic morphology may be associated with upregulation of another two genes constituting dendrite/neurite projection gene cluster such as *Crmp1* (collapsin response mediator protein 1) and *Cntnap4* (contactin associated protein-like 4). *Crmp1* encodes a member of a family of cytosolic phosphoproteins expressed exclusively in the nervous system. Encoded protein is thought to be a part of the semaphorin signal transduction pathway implicated in semaphorin-induced growth cone collapse. CRMP1 is necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Furthermore, it plays a role in axon guidance while *Cntnap4* product belongs to the neurexin family, members of which function in the nervous system as cell adhesion molecules and receptors (Pasterkamp and Giger [@CR88]; Yamashita et al. [@CR115]).

Neural remodeling is a fundamental process by which the brain responds to environmental influences during stress. In PFC of stressed LA mice, we identified upregulation of three stress-responsive genes involved in myelin function: *Gpm6a*, *Mal*, and *Mog*. *Gpm6a* codes glycoprotein M6a which plays an important role in neurite outgrowth and synapse formation (Alfonso et al*.*[@CR3]). This gene is downregulated in the hippocampus of both socially and physically stressed animals, and this effect can be reversed by antidepressant treatment (Alfonso et al. [@CR3]). In our previous study, we found downregulation of *Gpm6a* in hippocampus of LA mice after CMS (Lisowski et al*.*[@CR63]). GMP6A may play a role in the stress-induced hippocampal alterations that are found in psychiatric disorders (Boks et al. [@CR18]). *Mal* encodes integral membrane protein belonging to the MAL family of proteolipids involved in myelin biogenesis and function. The product of *Mog* is a membrane protein MOG, expressed on the oligodendrocyte cell surface and the outermost surface of myelin sheaths. Downregulation of cortical *Mog* expression was found to be involved in schizophrenia and major depressive disorder (Aston et al*.*[@CR7]; Martins-de-Souza et al. [@CR70]). In the other hand, MOG is detectable in multiple sclerosis (MS) patients and is suspected to be involved in pathogenesis of MS (Stern and Keskin [@CR101]). Upregulation of genes that encode structural components of myelin such as *Gpma6*, *Mal*, and *Mog* in PFC of LA mice could be an adaptive mechanism of stress response dependent on stress procedure duration or individual vulnerability.

CMS induces neuroadaptive changes that could address clinical findings in depressed patients (Frodl et al*.*[@CR38]; Gould et al. [@CR42]; Lucassen et al*.*[@CR66]; Rajkowska [@CR92]; Sanacora et al*.*[@CR95]). Recent clinical (Uezato et al*.*[@CR106]) and preclinical studies (Garcia-Garcia et al*.*[@CR40]; Tordera et al. [@CR103]) have linked decreased levels of the synaptic vesicle protein vesicular glutamate transporter 1 (VGLUT1) to depressive-like behavior. In addition, recent studies with heterozygous VGLUT1 knockout mice suggest that decreased VGLUT1 levels affects glutamate transmission and induces depressive-like behavior comorbid with anxiety and impaired recognition memory (Balschun et al*.*[@CR10]; Tordera et al*.*[@CR103]). On the other hand, in our study, we noticed upregulation of *VGluT1* (also *Slc17a7*) in HA CMS mice and downregulation of metabotropic glutamate receptor 5 (*Grm5*) in LA CMS mice. *Grm5* is a subtype of group I glutamate receptors, is highly expressed in limbic forebrain regions, and is thought to modulate anxiety-related processes. The blockade of *Grm5* by specific antagonist 2-methyl-6-(phenylethynyl) pyridine, reduce extracellular norepinephrine, the impact of which may contribute to their anxiolytic actions (Page et al*.*[@CR83]). We suggest that the downregulation of *Grm5* together with disregulation of other genes included in *signal transduction* and *response to stress* clusters of LA CMS mice and upregulation of *VGluT1* could be a mechanism of adaptation to stress of stress resistant individuals. Moreover, upregulation of *VGluT1* is according to our previous study in which we have observed significant upregulation of *VGluT1* and *VGluT2* mRNA in the hippocampus of LA mice after CMS procedure (Lisowski et al*.*[@CR63]).

In HA mice, we observed significant upregulation of arginine vasopressin transcript (*Avp*). Activation of the hypothalamic-pituitary-adrenal system by psychosocial stress is accompanied by an increase in peripheral plasma AVP levels in human study (Zimmermann et al*.*[@CR116]). Repeated stress is known to induce an increased vasopressin (AVP) expression in paraventricular corticotrophin-releasing hormone (CRH) neurons that is supposed to enhance the ACTH-releasing capacity of these cells. Acute immobilization produced a significant increase in the average AVP and CRF mRNA levels in the medial parvocellular subdivisions of the paraventricular nucleus (PVN) (Aubry et al*.*[@CR8]). PVN AVP mRNA levels are more sensitive to glucocorticoid negative feedback than are the levels of CRH mRNA (Makino et al. [@CR68]). In the brain as a whole, AVP acts on wide array of neurons. AVP might also modulate emotional memory and anxiety (Koob [@CR57]). We suggest that in CMS, a robust increase in PFC of *Avp* mRNA level is a mechanism contributing to the maintenance of a HPA response after repeated stress. Besides hypothalamus and amygdala, the PFC excitatory actions of AVP released from cortical neurons may also contribute to the behavioral stress response.

In our previous study, we found that naïve HA mice display robust upregulation of tridecapeptide neurotensin (NT) receptor transcript (*Nts2r*) in hippocampus as compared to naïve LA mice (Lisowski et al. [@CR64]). Recently, it became evident that NT is involved in responsiveness to both pain and stressful stimuli, suggesting that this neurotransmitter may be involved in the phenomenon of non-opioid SIA (Dobner [@CR30]). The release of endogenous NT in response to stress requires the presence of NTS2 to stimulate corticotropin-releasing factor-induced elevation of plasma corticosterone (Lafrance et al. [@CR58]). These data highlight the significance of NTS2 as a novel target for the treatment of pain and stress-related disorders. In the current study, we observed significant upregulation of neurotensin transcript (*Nts*) in HA mice after CMS procedure. This gene encodes a common precursor for two peptides, neuromedin N and neurotensin. Neurotensin is a secreted tridecapeptide, which is widely distributed throughout the central nervous system, and may function as a neurotransmitter or a neuromodulator. It may be involved in dopamine-associated pathophysiological events. Both, *Nts* and *Drd1a* were clustered in group of genes involved in homeostatic process/regulation of biological quality in HA CMS mice. In addition to the role of NT in the regulation of nociceptive processing, there is accumulating evidence suggesting that NT is involved in hormonal, neural, and behavioral stress-related responses. NT turnover is also altered under physiological stress. Exposure to various stressors, such as immobilization or cold-water swim, induces an up-regulation of the NT precursor mRNA in several hypothalamic regions, including the medial preoptic area and the paraventricular nucleus (Ceccatelli and Orazzo [@CR23]; Seta et al. [@CR97]). Since there are also studies that provided the evidence for the involvement of NT in the development of neuropsychiatric disorders, we suggest that the involvement of NT in the regulation of the hypothalamo--pituitary--adrenal gland axis during chronic stress should be considered in the context of vulnerability phenotypes.

Among differentially expressed genes of *response to stress* cluster in LA CMS mice, we identified robust upregulation of calpain 2 (*Capn2*) and downregulation of corticotrophin-releasing hormone receptor 1 (*Crhr1*). Calpains are a group of calcium-dependent protease that plays a significant role in synaptic plasticity, cell motility, and neurodegeneration (Liu et al*.*[@CR65]; Wu and Lynch [@CR114]). Calpain-mediated spectrin degradation has been implicated in dendritic spine changes associated with LTP induction (Lynch and Baudry [@CR67]; Vanderklish and Bahr [@CR107]; Vanderklish et al. [@CR108]). In addition, calpain inhibitors block LTP induction in vitro and in vivo (Denny et al*.*[@CR28]; Staubli et al. [@CR99]). Despite the quite well-known physiological role of m-calpain in brain, it is not clear under which conditions m-calpain could be activated (Friedrich [@CR37]); however, based on our data, the chronic stress-dependent upregulation of *Capn2* in PFC is possible in vulnerable phenotypes.

PFC contains "hot spots" of receptors for key stress mediators such as β1-adrenoceptors (β1R), CRH receptors (CRHR1, CRHR2), mineralocorticoid, and glucocorticoid receptors (MR, GR) (Joels and Baram [@CR50]). In LA CMS mice, we observed downregulation of *Crhr1* that encodes a G-protein-coupled receptor that binds neuropeptides of the CRH family. Actions of stress-induced CRH release are mediated primarily through binding to CRHR1 while binding to CRHR2 exert effects at long timescale and might function to shut down the stress response (Bale et al. [@CR9]; Coste et al*.*[@CR24]; Muller et al. [@CR78]). Quantity of *Crhr1* mRNA in rodent PFC in contrast to *Crhr2* is high (Aguilera et al*.*[@CR1]). Significant downregulation of *Crhr1* transcription suggests decreased CRH binding following chronic stress in PFC. It is likely that transcriptional regulatory mechanisms that permit rapid changes in *Crhr1* activity in PFC are important for adaptation of corticotroph responsiveness to continuous changes in physiological demands. In this regard, pituitary *Crhr1* mRNA levels decrease following glucocorticoid administration and recover only when circulating glucocorticoids decline below stress levels (Ochedalski et al. [@CR82]). These findings suggest that the glucocorticoids contribute to the decrease in cortical Crhr1 mRNA during stress. The mechanism regulating PFC *Crhr1* mRNA levels during stress is likely to involve increased exposure of the cortical corticotroph to glucocorticoids, CRH and AVP.

Insulin plays a role in the structural responses of the brain to stressors. Lack of insulin causes a decrease in dentate gyrus neuron number and leads to increased remodeling of dendrites of CA3 neurons that is further accelerated by repeated restraint stress. Stress and hyperglycemia both increase oxidative stress in the brain and this is likely to contribute, over time, to impaired neural function in chronic stress and diabetes. In the present study, we found that in HA mice, genes involved in hormone secretion including insulin secretion genes were deregulated. Among them, we found upregulation of prolactin receptor (*Prlr*). Study showed that prolactin (PRL) is a neuromodulator of behavioral and neuroendocrine stress coping in the rat (Blume et al*.*[@CR17]; Torner et al*.*[@CR105]). Downregulation of brain prolactin receptors increased anxiety-related behavior demonstrating an anxiolytic effect of PRL acting at brain level (Torner et al. [@CR105]). Furthermore stress-induced increase of corticotropin secretion was decreased after chronic intracerebroventricular infusion of PRL (Torner et al. [@CR105]). Fujikawa ([@CR39]) showed that PRL levels increase in response to stress acting on the central nervous system and plays an important role in helping to protect against acute stress-induced hypocalcemia. Taken together, prolactin acting at brain level has to be considered as a novel regulator of stress response and HPA axis reactivity in PFC.

The data from the current study indicate that in addition to abnormalities related to neurons, communication in chronic stress may be altered due to functional changes in multiple components of signal transduction mechanisms. Significant numbers of differentially expressed genes in our mouse models displayed altered expression in humans with neurodegenerative diseases. Also of interest was the decreased expression of *Drd1a*, *Crhr1*, *Grm5*. Its altered activity has been associated with various human neurological disorders including schizophrenia, Alzheimer\'s disease and Huntington\'s disease. Regulation may serve as an adaptive mechanism in response to prolonged stress, and may be relevant to chronic stress-induced depression in PFC region.

Conclusions {#Sec20}
===========

To summarize, transcriptional profiling revealed evidence of changes in cell systems that might contribute to structural and functional abnormalities in the prefrontal cortex in individuals with different genetic backgrounds. Further studies are necessary to confirm these findings and to determine how these changes in gene expression are switched at different time-points of chronic stress. In genetically predisposed individuals, an imbalance in control mechanisms of gene expression can introduce a bias towards stress-related brain disease after adverse experiences. New candidate genes that serve as biomarkers for the prediction of stress-vulnerable phenotypes should continue to be tested. The relevance of our findings to human stress, depression, or anxiety is yet unclear; however, our animal model for chronic stress allowed insights into molecular processes. Further assessment of alterations in gene expression in brain regions are required to determine the possible role of stressful situation during an adaptation or habituation to repeated stress. In addition, pharmacological validation should be performed to confirm that drugs active in the treatment of anxiety or depression could reversed the stress-induced gene expression alteration. It should be noted that despite the identification of different genes in each mice strain, the exposure to stress caused a similar biological effect based on GO database enrichements. The study results show that many genetic factors, not one allele, determine how an individual responds to stress and stressful situation.

Limitations {#Sec21}
===========

The assessment of the possible chronic stress-related alterations in the PFC transcriptome may be relevant to the mechanisms involved in stress-induced neuropsychopathologies. Transcriptomic model reduces the biological complexity of stress response to the genetic level, whereas it should include genomic, epigenomic, and proteomic levels in the context of systems biology. Our CMS model assumes that cortical cells can modify metabolic functions related to animals\' behavior. Another thing is that many metabolic or cell cycle-related genes were identified among the differentially expressed transcripts certainly points to the possibility that the observed expression patterns could be only indirectly related to distinct LA and HA mice phenotypes and may underline differences in other organs, e.g., endocrine system functions. We speculate that the selection for high and low SIA may be the basis of strain differences at the brain metabolic level. Genes are tested at one time point, often not based on a biological system, e.g., circadian genes and circadian rhythm. Thus, further studies are needed to determine how the transcriptomic profiles of particular brain structures distributing in particular time points of chronic stress to unravel the differences between adaptation and disease. Furthermore, development of mouse models where identified genes are either knocked-down or overactive and crossing them with models of, e.g., Alzheimer\'s disease, Parkinson\'s disease, multiple sclerosis or amyotrophic lateral sclerosis, to see if it can influence neurodegeneration could reveal their impact on neuropsychopathologies. Screening for epigenetics compounds as DNA methylation and non-coding RNA action that can be altered is also required. Integration of genomics and epigenomics could better explain the chronic stress-related psychopathologies.
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